Washington, DC—R. Paul Robertson, MD, President Emeritus and Principal Scientist of the Pacific Northwest Diabetes Research Institute in Seattle, WA, has been named editor-in-chief of the Endocrine Society’s Journal of Clinical Endocrinology & Metabolism (JCEM).
JCEM is the world's leading peer-reviewed journal for endocrine clinical research and cutting-edge clinical practice reviews. The journal provides the latest in-depth coverage of new developments that contribute to the understanding, diagnosis and treatment of endocrine and metabolic disorders. According to Thomson Reuters’ most recent Journal Citation Report covering 2012, JCEM garnered the most citations among the 121 journals in the “Endocrinology & Metabolism” category.
“It is a huge honor to be chosen to lead such a prominent journal in the medical and scientific community,” Robertson said. “JCEM is internationally known for the strength of its clinical and translational research. I am eager to continue and build on the tradition of delivering groundbreaking and meaningful manuscripts to JCEM’s continually growing readership.”
Robertson will serve a five-year term as Editor-in-Chief beginning Jan. 1, 2015. He has previously served as Editor-in-Chief of the Society’s journal Endocrine Reviews and Founding Editor-in-Chief of the book series Translational Endocrinology & Metabolism.
“Dr. Robertson’s extensive experience and passion for endocrine scholarship make him an excellent choice to lead one of the field’s most authoritative peer-reviewed biomedical research journals,” said Barbara Byrd Keenan, executive director and CEO of the Endocrine Society. “The Society is honored to have him taking the helm of JCEM.”
In addition to his work at the Pacific Northwest Diabetes Research Institute, Robertson is a professor of medicine at the University of Minnesota and a professor of medicine and pharmacology at the University of Washington in Seattle. He is a past president of both the American Diabetes Association (ADA) and the Western Society for Clinical Investigation and was Editor-in-Chief of Diabetes, the lead research journal of the ADA. Robertson is actively investigating both basic science and clinical aspects of diabetes. He has published more than 350 articles and lectured around the world.
Founded in 1916, the Endocrine Society is the world’s oldest, largest and most active organization devoted to research on hormones and the clinical practice of endocrinology. Today, the Endocrine Society’s membership consists of over 17,000 scientists, physicians, educators, nurses and students in more than 100 countries. Society members represent all basic, applied and clinical interests in endocrinology. The Endocrine Society is based in Washington, DC. To learn more about the Society and the field of endocrinology, visit our site at www.endocrine.org. Follow us on Twitter at https://twitter.com/#!/EndoMedia.